Each time the heart contracts, it sends out an electrical signal. The signal is generated by the flow of electrolytes through passageways in the heart called "ion channels." Electrolytes, or ions, are sodium, potassium, magnesium and calcium. Class I medications block sodium channels in heart cells, which decrease the conduction of electrical signals from cell to cell in the heart. |
|
|
|
![]() |
Class IC antiarrhythmics are strong sodium channel blockers. They also slow nerve impulses in the heart, but have little effect on repolarization. They may be used for supraventricular and some ventricular arrhythmias.
|
![]() |
There is a chance that some antiarrhythmic drugs (and other types of drugs) may cause new heart rhythm problems, or make existing ones worse. If you have an arrhythmia, it is important to consult with an electrophysiologist or other physician who is an expert in heart rhythm disorders and the medications available to treat them. More than 80 marketed drugs, including some that are not used for heart problems, have been found to block potassium channels, prolong the QT interval (the time it takes the heart to recharge after each beat) and induce a fatal heart rhythm called torsades de pointes in some individuals. [more] |
|
Type II antiarrhythmics are called beta-adrenergic antagonists, or Beta Blockers. | ||
Beta-blockers are used in the treatment of high blood pressure (hypertension), to relieve angina (chest pain) and in heart attack patients to help prevent additional heart attacks. Beta-blockers also are used to correct some irregular heartbeats. They affect the response to nerve impulses in certain parts of the body, decrease the heart's need for blood and oxygen and reduce its workload. They also help the heart beat more regularly. Some common beta-blockers are: | ||
|
![]() |
|
Type III antiarrhythmics are called potassium channel blockers. | |||
|
They slow nerve impulses by acting directly on the heart tissues. Type III medications lengthen the duration of repolarization without affecting the heart's normal electrical conduction. Efforts to develop new antiarrhythmic drugs have focused on Type III medications because they are less likely to adversely affect the heart's pumping ability and they act on tissues in both the upper and lower chambers of the heart. Type III drugs used to treat heart rhythm disorders are:
|
|
Type IV antiarrhythmics are calcium antagonists, or calcium channel blockers. | |||
![]()
|
These drugs widen the blood vessels and may decrease the heart's pumping strength. They are often used to treat high blood pressure, but usually are not prescribed for people with heart failure or other structural damage to the heart. (They may be used to treat heart faliure in people with stiff hearts) They also may be useful in treating coronary artery disease, or CAD (clogged blood vessels to the heart).
Some arrhythmias are treated with:
|